Professional Documents
Culture Documents
Babe Hospital
Craiova
Introduction
Tuberculosis (TB) remains one of the worlds
deadliest communicable diseases.
TB meningitis is one of the worst forms of
extrapulmonary tuberculosis whose evolution,
untreated, is invariably fatal.
The clinical features of TBM are the result of
basilar meningeal fibrosis and vascular
inflammation.
Introduction
Introduction
The use of antitumor necrosis factor-alpha
(TNF) neutralizing antibody has also been
associated with increased risk of
extrapulmonary TB including TBM.
The mechanisms by which TNF is important in
initial and long-term control of tuberculosis are
not clear, and are likely to be numerous.
Patient S. V.
History of present
illness
Headache
not relieved
by
medications
Cough
Simptomatolo
gy
ks
e
we
we
ek
Vomiting
Generalized
weakness
Chills
52 years old female from an urban environment;
No history of trauma
Anamnesis
Past medical history:
Psoriasis in treatment for 2 years with anti-TNF;
Not suffering for diabetes, hepatitis
Family diseases:
no significant family medical history known
No family history of the following:
Diabetes
Cancer
TB
Hepatitis
Anamnesis
Social history:
Lives in a flat;
Pensioner;
Got 1 kid (female) 30 y.o.;
No tobacco, alcohol or drug use;
Drinks coffee (1-2/day);
No recent foreign travel;
No pets
Anamnesis
Regular and acute medications:
Remicade 100 mg (Infliximabum);
Paracetamol (Acetaminophen)
Allergies:
none known
Clinical examination
HEENT
Awake, cooperative but difficulty
in speaking
Neck rigidity
Clinical examination
Coarse rales
Chest/
Lungs
Clinical examination
No organomegaly
Abdomen
Clinical examination
Erythemato-squamous elements
localized on skin of the large joints
of upper and lowerlimbs
Extremitie
s
1 diagnosis
st
Laboratory data
Normal WBC (6,3*10^3u/L), an easier
lymphopenia (14%);
Very accelerated ESR(55mm/1h; 70mm/2h);
GPT=74 U/L - hepatocytolisis;GOT=62 U/L ;
Alkaline phosphatase 135 ;
Gamma GT 115;
Glucose 127;
Urinalysis rare flat epithelial, rare WBC, rare
microbial flora. acid pH , density - 1030.
Laboratory data
CXR
micro point opacities
Laboratory data
Lumbar puncture Clear CSF
Biochemistry
Cellular count
Glucose
concentration
15,1 mg/dl
Pandy reaction
+++
Elevated
protein
66mg%
Chlorides
760 mg%
255/mmc
(10% PMN,
90% Ly)
Laboratory data
Pneumology examination
TB meningitis
Miliary pulmonary TB form
Dermatologic examination
Patient with known with severe psoriasis in
treatment with anti-TNF alpha for 2 years
(Infliximabum 400mg at 2 months), last parenteral
administration at 9 11 2012 with the remission of
skin lesions accuse from 3-4 days headache and
asthenia.
Recommendations : infliximab discontinuation
Diagnosis
Diagnosis
1.TB MENINGITIS
2.MILIARY PULMONARY TB FORM
3.DRUG-INDUCED HEPATITIS
4.ORAL THRUSH
5.PSORIASIS IN BIOLOGICAL THERAPY
Differential diagnosis
Fungal Meningitis
Viral meningoencephalitis
Parameningeal Infection
Sphenoid sinusitis, brain abscess, spinal epidural
abscess
Treatment
Zile de tratament/
medicament
1
0
1
1
1
2
1
3
1
4
1
5
1
6
+ + + + + +
+ + + + + + + + + +
RIF cp 150mg II
(pyrazinamidum)
+ + + + + +
+ + + + + + + + + +
PZM cp 500 mg II
(rifampicinum)
+ + + + + +
+ + + + + + + + + +
EMB cp 400mg II
(ethambutolom)
+ + + + + +
+ + + + + + + + + +
Treatment
Treatment days/
medicins
1
0
1
1
1
2
1
3
1
4
1
5
1
6
+ + -
Dexamethasone fi II
1 fi* 2/day, h8-h16
+ + + + + +
+ + + + + + + + + +
Sodium Chloride
fl 500 ml I
+ + + + + +
+ + + +
Glucoza 5%
+ + + + + +
+ + + + + + + + + +
Stamicin dj III
+ + + + + +
+ + + + + + + + + +
Omez tb I
+ + + + + +
+ + + + + + + + + +
+ + + + + + + + + +
Treatment
Zile de tratament/
medicament
17
18
19
22
23
2
4
+ + + +
+ + + + + + +
RIF cp 150mg II
(pyrazinamidum)
+ + + +
+ + + + + + +
PZM cp 500 mg II
(rifampicinum)
+ + + +
+ + + + + + +
EMB cp 400mg II
(ethambutolom)
+ + + +
+ + + + + + +
Dexamethasone fi II
1 fi* 2/zi, h8-h16
+ + + +
+ + + + + + +
Ranitidine cpr II
+ + + +
+ + + + + + +
B6 vitamin fl I
+ + + +
+ + + + + + +
Liv 52 cpr II
+ + + +
+ + + + + + +
2
0
2
1
2
5
2
6
2
7
2
8
2
9
3
0
Evolution day 1
SUBJECTIVE
OBJECTIVE
ASESSMENT
PLAN
Febrile episode
(max 38,4C)
Headache
Difficulty in
speaking
Generalized
weakness
Not vomiting
Stable VS
Cooperative
No meningeal
signs
CRX - micro
point opacities
disseminated in
both lung
fields
TB meningitis
Na correction
Start Mannitol
Start TSS
Evolution day 3
SUBJECTIVE
OBJECTIVE
ASESSMENT
PLAN
Afebrile episode
No headache
Generalized
weakness
Not vomiting
Stable VS
Cooperative
No meningeal
signs
TB meningitis
Continue
medications
Evolution day 10
Lumbar puncture Clear CSF
Biochemistry
Cellular count
Glucose
concentration
32,6 mg/dl
Pandy reaction
+++
Elevated
protein
132mg%
Chlorides
750 mg%
96/mmc (100%
limfocite)
Evolution
4 weeks later, on culture of LCR was
developed M. tuberculosis
She was discharged after 1 month of
hospitalisation with normal laboratory
data and no symptoms
She continuated anti-tuberculosis
treatment for 12 month
She permanently discontinued
biological therapy for psoriazis
Complications of TB
meningitis
Hydrocephalus
CVA
Coma
Motor deficits
Seizures
Abnormal behaviours
Case Particularity
The particularity of these case consist in
the atipical aspects-both:
clinical ( lack of fever, absence of meningeal
irritation) and
biological ( no biological inflammatory
syndrome, a slightly modified CSF
biochemistry)
THANK YOU!